Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “NASH - Nonalcoholic Steatohepatitis; NAFLD - Nonalcoholic Fatty Liver Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)WithdrawnNCT04395950
What this trial is testing

Effects of ACC Inhibitor on Lipid and Lipoprotein Metabolism

Who this might be right for
NASH (Nonalcoholic Steatohepatitis)NAFLD (Nonalcoholic Fatty Liver Disease)
Columbia University
Testing effectiveness (Phase 2)Study completedNCT03987074
What this trial is testing

Safety, Tolerability, and Efficacy of Monotherapy and Combination Regimens in Participants With Nonalcoholic Steatohepatitis (NASH)

Who this might be right for
Nonalcoholic Steatohepatitis
Gilead Sciences 109
Not applicableUnknownNCT03254563
What this trial is testing

Copeptin and Nonalcoholic Fatty Liver Disease

Who this might be right for
NAFLD
University of Colorado, Denver 60
Post-approval studies (Phase 4)Study completedNCT05616442
What this trial is testing

Ketotifen in Non-Alcoholic Fatty Liver Disease Patients

Who this might be right for
Hepatic Disease
Tanta University 60
Testing effectiveness (Phase 2)Study completedNCT02854605
What this trial is testing

Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Participants With Nonalcoholic Steatohepatitis (NASH)

Who this might be right for
Nonalcoholic Steatohepatitis (NASH)
Gilead Sciences 140
Not applicableUnknownNCT03534908
What this trial is testing

Nonalcoholic Fatty Liver Disease and Cardiovascular Disease: the Correlation Analysis and Risk Prediction Model Study

Who this might be right for
NAFLDCardiovascular Diseases
Wuhan University 5,000,000
Not applicableUnknownNCT05855239
What this trial is testing

Quantification of Hepatic Steatosis With Different Ultrasound Frequency

Who this might be right for
Fatty LiverFatty Liver, NonalcoholicUltrasound
Jong Keon Jang 120
Not applicableStudy completedNCT00262964
What this trial is testing

Obesity and Nonalcoholic Fatty Liver Disease

Who this might be right for
Non-alcoholic Fatty Liver Disease
Washington University School of Medicine 51
Large-scale testing (Phase 3)Study completedNCT06309992
What this trial is testing

Test Whether Survodutide Helps People Living With Obesity or Overweight and With a Confirmed or Presumed Liver Disease Called Non-alcoholic Steatohepatitis (NASH) to Reduce Liver Fat and to Lose Weight (SYNCHRONIZE-MASLD)

Who this might be right for
ObesityNon-Alcoholic SteatoHepatitis (NASH)
Boehringer Ingelheim 218
Not applicableUnknownNCT06257732
What this trial is testing

Different Exercise Modalities in the Treatment of NAFLD and Their Impact on Myokines

Who this might be right for
NAFLDNonalcoholic Fatty Liver DiseaseFatty Liver, Nonalcoholic+1 more
Yeditepe University 144
Testing effectiveness (Phase 2)Study completedNCT04052516
What this trial is testing

A Phase 2b Study of Icosabutate in Fatty Liver Disease

Who this might be right for
Non Alcoholic Steatohepatitis (NASH)
NorthSea Therapeutics B.V. 280
Not applicableStudy completedNCT03847116
What this trial is testing

Alcohol Consumption and Type 2 Diabetes Mellitus Risk in Nonalcoholic Fatty Liver Disease

Who this might be right for
Nonalcoholic Fatty Liver DiseaseLight-to-moderate Alcohol ConsumptionType2 Diabetes Mellitus
Ningbo No. 1 Hospital 14,014
Not applicableNot Yet RecruitingNCT06623084
What this trial is testing

Integrated Phenotyping of the Gut-plAtelet-Liver AXIS in the Progression of Chronic Liver Disease (iGAL-AXIS)

Who this might be right for
Non-alcoholic Fatty Liver Disease (NAFLD)NASH - Nonalcoholic SteatohepatitisCirrhosis+1 more
Stefania Basili 132
Testing effectiveness (Phase 2)Ended earlyNCT02244944
What this trial is testing

Ezetimibe-Ursodiol Combination Therapy on Biomarkers of Liver Function and Sterol Balance in Subjects With NAFLD

Who this might be right for
Nonalcoholic Fatty Liver Disease (NAFLD)
Gregory Graf, PhD 2
Testing effectiveness (Phase 2)Study completedNCT00062764
What this trial is testing

Treating Nonalcoholic Steatohepatitis With Pioglitazone

Who this might be right for
Hepatitis
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 18
Not applicableStudy completedNCT04389593
What this trial is testing

Comparative and Additive Diagnostic Performance of Magnetic Resonance Elastography (MRE) and Corrected-T1 (cT1) for Fibrosis and Inflammation in Nonalcoholic Steatohepatitis (NASH) Using Histology As Reference

Who this might be right for
Nonalcoholic Fatty LiverNonalcoholic SteatohepatitisLiver Fibroses+1 more
University of California, San Diego 30
Not applicableStudy completedNCT05370053
What this trial is testing

The Availability of the Enhanced Liver Fibrosis (ELF) Test Affects the Rate of Diagnosis of Nonalcoholic Steatohepatitis (NASH) With Fibrosis in Patients Referred to Hepatology

Who this might be right for
Fatty LiverNAFLD
University of Kansas Medical Center 450
Testing effectiveness (Phase 2)Ended earlyNCT04065841
What this trial is testing

Efficacy, Safety and Tolerability of the Combination of Tropifexor & Licogliflozin and Each Monotherapy, Compared With Placebo in Adult Patients With NASH and Liver Fibrosis.

Who this might be right for
Non Alcoholic Steatohepatitis (NASH)
Novartis Pharmaceuticals 234
Not applicableStudy completedNCT07146815
What this trial is testing

PolyCystic Ovary Syndrome as Suggested Risk Group for Non-Alcoholic Fatty Liver Disease

Who this might be right for
NAFLD (Nonalcoholic Fatty Liver Disease)Polycystic Ovarian Syndrome (PCOS)
Ziekenhuis Oost-Limburg 157
Not applicableActive Not RecruitingNCT04383951
What this trial is testing

Safety and Efficacy of Ketogenic Diet for Promoting Weight Loss in Obese Individuals With Compensated NASH Cirrhosis

Who this might be right for
NASH - Nonalcoholic SteatohepatitisCirrhosis, Liver
Indiana University 40
Next Page